{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:38:32Z","timestamp":1771069112119,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10620-025-08849-8","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T18:45:13Z","timestamp":1738003513000},"page":"1167-1177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Usefulness of Novel Image-Enhanced Endoscopy for Predicting Maintenance of Clinical Remission in Ulcerative Colitis"],"prefix":"10.1007","volume":"70","author":[{"given":"Yukiyo","family":"Mamiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syohei","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Syu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Koshibu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Horio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Kurosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsubasa","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"8849_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB et al. Ulcerative colitis. Lancet 2017;389:1756\u20131770. https:\/\/doi.org\/10.1016\/S0140-6736(16)32126-2.","journal-title":"Lancet"},{"key":"8849_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cgh.2017.06.016","volume":"16","author":"M Fumery","year":"2018","unstructured":"Fumery M, Singh S, Dulai PS et al. Natural history of adult ulcerative colitis in population-based cohorts: a systematic review. Clin Gastroenterol Hepatol 2018;16:343\u2013356. https:\/\/doi.org\/10.1016\/j.cgh.2017.06.016.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8849_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cgh.2016.01.015","volume":"14","author":"SC Shah","year":"2016","unstructured":"Shah SC, Colombel JF, Sands BE et al. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:1245\u20131255. https:\/\/doi.org\/10.1016\/j.cgh.2016.01.015.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8849_CR4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","volume":"61","author":"MF Neurath","year":"2012","unstructured":"Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 2012;61:1619\u20131635. https:\/\/doi.org\/10.1136\/gutjnl-2012-302830.","journal-title":"Gut"},{"key":"8849_CR5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1897","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1897;317:1625\u20131629. https:\/\/doi.org\/10.1056\/NEJM198712243172603.","journal-title":"N Engl J Med"},{"key":"8849_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.dld.2014.07.010","volume":"46","author":"M Daperno","year":"2014","unstructured":"Daperno M, Comberlato M, Bossa F et al. Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the italian group for inflammatory bowel disease (IG-IBD). Dig Liver Dis 2014;46:969\u2013973. https:\/\/doi.org\/10.1016\/j.dld.2014.07.010.","journal-title":"Dig Liver Dis"},{"key":"8849_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2020.06.043","volume":"159","author":"H Yoon","year":"2020","unstructured":"Yoon H, Jangi S, Dulai PS et al. Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis. Gastroenterol 2020;159:1262\u20131275. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.043.","journal-title":"Gastroenterol"},{"key":"8849_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/ecco-jcc\/jjv210","volume":"10","author":"K Ikeya","year":"2015","unstructured":"Ikeya K, Hanai H, Sugimoto K et al. The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo endoscopic score. J Crohns Colitis 2015;10:286\u2013295. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv210.","journal-title":"J Crohns Colitis"},{"key":"8849_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/ecco-jcc\/jjy092","volume":"12","author":"R Ozaki","year":"2018","unstructured":"Ozaki R, Kobayashi T, Okabayashi S et al. Histological risk factors to predict clinical relapse in ulcerative colitis with endoscopically normal mucosa. J Crohns Colitis 2018;12:1288\u20131294. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy092.","journal-title":"J Crohns Colitis"},{"key":"8849_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1756283X16645501","volume":"9","author":"Y Ninomiya","year":"2016","unstructured":"Ninomiya Y, Oka S, Tanaka S et al. Clinical impact of dual red imaging in colorectal endoscopic submucosal dissection: a pilot study. Therap Adv Gastroenterol 2016;9:679\u2013683. https:\/\/doi.org\/10.1177\/1756283X16645501.","journal-title":"Therap Adv Gastroenterol"},{"key":"8849_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.gie.2022.11.019","volume":"97","author":"Y Hayashi","year":"2023","unstructured":"Hayashi Y, Takabayashi K, Kato M et al. Usefulness of texture and color enhancement imaging in assessing mucosal healing in patients with ulcerative colitis. Gastrointest Endosc 2023;97:759\u2013766. https:\/\/doi.org\/10.1016\/j.gie.2022.11.019.","journal-title":"Gastrointest Endosc"},{"key":"8849_CR12","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1007\/s00464-022-09852-0","volume":"37","author":"Y Hashimoto","year":"2023","unstructured":"Hashimoto Y, Kuribayashi S, Sato K et al. Validation of red dichromatic imaging score (RDI score) to evaluate the severity of ulcerative colitis. Surg Endosc 2023;37:3627\u20133633. https:\/\/doi.org\/10.1007\/s00464-022-09852-0.","journal-title":"Surg Endosc"},{"key":"8849_CR13","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","volume":"14","author":"JD Lewis","year":"2008","unstructured":"Lewis JD, Chuai S, Nessel L et al. Use of the noninvasive components of the mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008;14:1660\u20131666. https:\/\/doi.org\/10.1002\/ibd.20520.","journal-title":"Inflamm Bowel Dis"},{"key":"8849_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5518948","author":"T Sato","year":"2021","unstructured":"Sato T. TXI: texture and color enhancement imaging for endoscopic image enhancement. J Healthc Eng. 2021. https:\/\/doi.org\/10.1155\/2021\/5518948.","journal-title":"J Healthc Eng"},{"key":"8849_CR15","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1002\/deo2.325","volume":"4","author":"K Takabayashi","year":"2024","unstructured":"Takabayashi K, Kato M, Kaiai T. Clinical usefulness of image-enhanced endoscopy for the diagnosis of ulcerative colitis-associated neoplasia. DEN Open 2024;4:e325. https:\/\/doi.org\/10.1002\/deo2.325.","journal-title":"DEN Open"},{"key":"8849_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221118302","author":"T Uraoka","year":"2022","unstructured":"Uraoka T, Igarashi M. Development and clinical usefulness of a unique red dichromatic imaging technology in gastrointestinal endoscopy: a narrative review. Ther Adv Gastroenterol. 2022. https:\/\/doi.org\/10.1177\/17562848221118302.","journal-title":"Ther Adv Gastroenterol"},{"key":"8849_CR17","doi-asserted-by":"publisher","first-page":"E76","DOI":"10.1055\/s-0042-119393","volume":"5","author":"M Naganuma","year":"2017","unstructured":"Naganuma M, Yahagi N, Bessho R et al. Evaluation of the severity of ulcerative colitis using endoscopic dual red imaging targeting deep vessels. Endosc Int Open 2017;5:E76-82. https:\/\/doi.org\/10.1055\/s-0042-119393.","journal-title":"Endosc Int Open"},{"key":"8849_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.47.3.404","volume":"47","author":"K Geboes","year":"2000","unstructured":"Geboes K, Riddell R, \u00d6st A et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000;47:404\u2013409. https:\/\/doi.org\/10.1136\/gut.47.3.404.","journal-title":"Gut"},{"key":"8849_CR19","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/ecco-jcc\/jjad087","volume":"17","author":"L Peyrin-Biroulet","year":"2023","unstructured":"Peyrin-Biroulet L, Arenson E, Dt R et al. A comparative evaluation of the measurement properties of three histological indices of mucosal healing in ulcerative colitis: geboes score, robarts histopathology index and Nancy index. J Crohns Colitis 2023;17:1733\u20131743. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad087.","journal-title":"J Crohns Colitis"},{"key":"8849_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.dld.2023.07.011","volume":"56","author":"DG Ribaldone","year":"2024","unstructured":"Ribaldone DG, Parisio L, Variola A et al. Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: the SVEDO study, an IG-IBD study. Dig Liver Dis 2024;56:77\u201382. https:\/\/doi.org\/10.1016\/j.dld.2023.07.011.","journal-title":"Dig Liver Dis"},{"key":"8849_CR21","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s10620-020-06486-x","volume":"66","author":"C Perry","year":"2021","unstructured":"Perry C, Fischer K, Elmoursi A et al. Vedolizumab dose escalation improves therapeutic response in a subset of patients with ulcerative colitis. Dig Dis Sci 2021;66:2051\u20132058. https:\/\/doi.org\/10.1007\/s10620-020-06486-x.","journal-title":"Dig Dis Sci"},{"key":"8849_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ecco-jcc\/jjv158","volume":"10","author":"M Barreio-de Acosta","year":"2016","unstructured":"Barreio-de Acosta M, Vallejo N, de la Iglesia D et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): a longitudinal cohort study. J Crohns Colitis 2016;10:13\u201319. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv158.","journal-title":"J Crohns Colitis"},{"key":"8849_CR23","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","volume":"141","author":"JF Colombel","year":"2011","unstructured":"Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterol 2011;141:1194\u20131201. https:\/\/doi.org\/10.1053\/j.gastro.2011.06.054.","journal-title":"Gastroenterol"},{"key":"8849_CR24","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/ajg.2016.418","volume":"111","author":"P Sunhee","year":"2016","unstructured":"Sunhee P, Tsion A, Mark G et al. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol 2016;111:1692\u20131701. https:\/\/doi.org\/10.1038\/ajg.2016.418.","journal-title":"Am J Gastroenterol"},{"key":"8849_CR25","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.gie.2018.08.018","volume":"88","author":"RK Pai","year":"2018","unstructured":"Pai RK, Jairath V, Casteele NV et al. The emerging role of histologic disease activity assessment in ulcerative colitis. Gastrointest Endosc 2018;88:887\u2013898. https:\/\/doi.org\/10.1016\/j.gie.2018.08.018.","journal-title":"Gastrointest Endosc"},{"key":"8849_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/gast.2001.20912","volume":"120","author":"A Bitton","year":"2001","unstructured":"Bitton A, Peppercorn MA, Antonioli DA et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterol 2001;120:13\u201320. https:\/\/doi.org\/10.1053\/gast.2001.20912.","journal-title":"Gastroenterol"},{"key":"8849_CR27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1136\/gutjnl-2021-326376","volume":"71","author":"X Gui","year":"2022","unstructured":"Gui X, Bazarova A, Amor RD et al. PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system. Gut 2022;71:889\u2013898. https:\/\/doi.org\/10.1136\/gutjnl-2021-326376.","journal-title":"Gut"},{"key":"8849_CR28","doi-asserted-by":"publisher","unstructured":"Marietta lacucci, Parigi TL, Bazarova A et al (2023) Response to: Correspondence on \u201cPICaSSO Histologic Remission Indexa (RHRI) in ulcerative: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system\u201d by Wong et al. Gut 72:807\u2013808. https:\/\/doi.org\/10.1136\/gutjnl-2022-327661","DOI":"10.1136\/gutjnl-2022-327661"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-08849-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T15:45:55Z","timestamp":1743867955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-08849-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["8849"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-08849-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Takashi Taida received research grants from AbbVie G.K.. Jun Kato received honoraria from Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd., Abbvie G.K., Zeria Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, and JIMRO Co., Ltd., Mochida Pharmaceutical Co., Ltd.. Naoya Kato received honoraria from AbbVie G.K., Ohtsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Olympus Corporation, Eisai Co., Ltd., Tsumura & Co., Mochida Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Yakult Honsha Co., Ltd., Olympus Marketing, Inc., and Janssen Pharmaceutical K.K., and research funding from Ohtsuka Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Eisai Co., Ltd., Tsumura & Co., Nippon Kayaku Co., Ltd., and JIMRO Co., Ltd.. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}